Navigation Links
World Congress on Industrial Biotechnology: Germany Home to Top Biotech Research and Investment

BERLIN, April 25 /PRNewswire/ -- Processes and products based on biomass and industrial biotechnology offer significant business potential for the chemical industry in a wide range of applications such as bioplastics. A panel on developments in the field of industrial biotechnology in Germany will be held at the World Congress on Industrial Biotechnology and Bioprocessing (April 27-30, 2008) in Chicago, Illinois. The panel runs from 10:45am to 12:15pm on April 28th at the Hilton Chicago, 720 South Michigan Ave.

Research institutes play a pivotal role in biotechnology investments, and they are particularly strong in Germany as the country has many internationally recognized research centers. Dr. Steffen Rupp is the Head of Molecular Biotechnology of Fraunhofer IGB at the Fraunhofer Campus Stuttgart. His laboratory is a part of the wider network of Fraunhofer Institutes, a world-renowned research organization with affiliate centers all over Germany. He will discuss renewable feedstock such as residual biomass and ways of transforming such biomass into practical energy sources.

Chemical parks are a major attraction to Germany for the chemicals and biotechnology industries. Dr. Markus Wolperdinger is in charge of industrial biotech activities at InfraLeuna GmbH. InfraLeuna is the owner and infrastructure provider of one of Germany's largest chemical sites. The Leuna chemical site is home to over 100 companies, including some of the world's top chemical companies. Dr. Wolperdinger will discuss activities in the industrial biotechnology field that are currently taking place at the Leuna chemical site.

Dr. Karin Bronnenmeier will discuss the transfer of knowledge from fossil based refineries to future biorefineries. Specifically the integration of biotech expertise from biopharma biotech will be the focus of her presentation. She is the "know-how" manager for Biotechnology Plants at Linde-KCA-Dresden, the Competence Center Biotechnology at Linde's engineering division. The Linde Group is a leading gases and engineering company with 50,000 employees in over 70 countries.

Germany has the largest market in Europe for both the chemical industry and thermoplastics. The panel will address investment possibilities in Germany in a diversity of sectors, such as biotechnology and bioplastic.

Invest in Germany is the inward investment promotion agency of the Federal Republic of Germany. It provides investors with comprehensive support from site selection to the implementation of investment decisions.

Media Contact:

Eva Henkel

Invest in Germany

Phone: +49-30-200099-173

Fax: +49-30-200099-111


SOURCE Invest in Germany
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in Sirtuin Research and Development
2. febit to Introduce Geniom RT Analyzer(R) to U.S. Market at RNAi World Congress
3. Novavax CEO to Present at the World Vaccine Congress 2008
4. BIOTECON Diagnostics and MERCK KGaA start worldwide marketing alliance
5. Graphene used to create worlds smallest transistor
6. BioSpace and IBC Life Sciences Announce Career Fair Alliance For Drug Discovery & Development of Innovative Therapeutics World Congress
7. Researchers create the first thermal nanomotor in the world
8. WorldHeart 10-KSB Audit Report Includes Going Concern Qualification
9. Real-World Data from ARRIVE Registries Show Favorable Outcomes for TAXUS(R) Express(TM) Stent
10. CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide
11. Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide
Post Your Comments:
(Date:11/24/2015)... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be ... York on Wednesday, December 2 at 9:30 a.m. ET/6:30 ... CEO, will provide a corporate overview. th Annual ... 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola , ... corporate overview. --> th Annual Oppenheimer Healthcare Conference ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
(Date:11/24/2015)... ... November 24, 2015 , ... The Academy of Model Aeronautics (AMA), led by ... known as Multirotor Grand Prix, to represent the First–Person View (FPV) racing community. , ... have embraced this type of racing and several new model aviation pilots have joined ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... the remaining 11,000 post-share consolidation (or 1,100,000 pre-share ... "Series B Warrants") subject to the previously disclosed ... 23, 2015, which will result in the issuance ... to the issuance of such shares, there will ...
Breaking Biology Technology:
(Date:11/17/2015)... -- Vigilant Solutions announces today that Mr. Dick W. ... --> --> Mr. Boyce ... at TPG Capital, one of the largest global investment ... revenue.  He founded and led TPG,s Operating Group, which ... 1997 to 2013.  In his first role, he served ...
(Date:11/12/2015)... , Nov. 12, 2015  A golden retriever that ... muscular dystrophy (DMD) has provided a new lead for ... Hospital, the Broad Institute of MIT and Harvard and ... . Cell, pinpoints a ... "escape" the disease,s effects. The Boston Children,s lab of ...
(Date:11/11/2015)... --  MedNet Solutions , an innovative SaaS-based eClinical technology company ... to announce that it will be a Sponsor of the ... be held November 17-19 in Hamburg , ... iMedNet , MedNet,s easy-to-use, proven and affordable ... been able to deliver time and cost savings of up ...
Breaking Biology News(10 mins):